Stocks and Investing
Stocks and Investing
Tue, January 17, 2023
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
[ Tue, Jan 17th 2023
] - WOPRAI
Simeon Gutman Maintained (WOOF) at Hold with Decreased Target to $12 on, Jan 17th, 2023
Simeon Gutman of Morgan Stanley, Maintained "Petco Health and Wellness Company, Inc." (WOOF) at Hold with Decreased Target from $14 to $12 on, Jan 17th, 2023.
Simeon has made no other calls on WOOF in the last 4 months.
There are 6 other peers that have a rating on WOOF. Out of the 6 peers that are also analyzing WOOF, 2 agree with Simeon's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Michael Lasser of "UBS" Maintained at Hold with Decreased Target to $12 on, Thursday, December 1st, 2022
- Oliver Wintermantel of "Evercore ISI Group" Downgraded from Buy to Hold and Decreased Target to $12 on, Wednesday, October 19th, 2022
These are the ratings of the 4 analyists that currently disagree with Simeon
- Kate McShane of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $16 on, Thursday, December 1st, 2022
- Steven Shemesh of "RBC Capital" Maintained at Buy with Decreased Target to $16 on, Thursday, December 1st, 2022
- Anna Andreeva of "Needham" Maintained at Strong Buy with Decreased Target to $20 on, Monday, November 28th, 2022
- Zachary Fadem of "Wells Fargo" Maintained at Buy with Decreased Target to $14 on, Friday, November 18th, 2022
Contributing Sources